EUVIMEDEUVIMED entdecken
Open Access

A Comprehensive Study on the Diagnosis and Management of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features

Bayan A Alzumaili iD, Lauren N Krumeich, Reagan Collins iD, Timothy Kravchenko, Emad I Ababneh, Adam S Fisch, William C Faquin iD, Vania Nosé, Maria Martinez-Lage, Gregory W Randolph, Rajshri M Gartland, Carrie C Lubitz und 1 weitere

Thyroid® · 2023-05 · 33 (5) · 566-577

DOI: 10.1089/thy.2023.0035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, online erschienen am 04.05.2023. Verfasst von Bayan A Alzumaili und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma, Follicular. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Since the noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTPs) was introduced in 2016, most retrospective studies have included cases diagnosed as encapsulated follicular variant of papillary thyroid carcinoma. We investigate a cohort diagnosed with NIFTP at resection.

Methods

Retrospective institutional cohort of NIFTP from 2016 to 2022, including clinical, cytological, and molecular data for 319 cases (6.6% of thyroid surgeries, 183 cases as NIFTP-only).

Results

The patient cohort had unifocal or multifocal thyroid nodules. Female:male ratio was 2.7:1, mean age was 52 years and median NIFTP size was 2.1 cm. NIFTP was associated with multiple nodules in 23% patients ( n = 73) and 12% of NIFTP were multifocal ( n = 39). Fine needle aspiration (FNA) of NIFTP ( n = 255) were designated as nondiagnostic = 5%, benign = 13%, atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) = 49%, follicular neoplasm/suspicious for follicular neoplasm (FN/SFN) = 17%, suspicious for malignancy = 12%, or malignant = 4%. Molecular alterations were identified in 93% ( n = 114), RAS or RAS -like. Thyroid Imaging Reporting and Data System (TI-RADS) score 4 was recorded in 50% of NIFTP, followed by scores 3 and 5 (26% and 20%, respectively). We also investigated the factors associated with extent of surgery. In our NIFTP-only group ( n = 183), 66% were identified after hemithyroidectomy (HT) and 34% after total thyroidectomy (TT). On univariate analysis, TT patients demonstrated higher Bethesda category by FNA, more often had aberrant preoperative thyroid function, and/or underwent an FNA of additional nodule(s). With multivariable regression, Bethesda V NIFTP, in the presence of other nodules being evaluated by FNA and aberrant preoperative thyroid function, independently predicts TT. Bethesda II NIFTP correlated significantly with HT. Fifty-two patients (28%) with NIFTP-only had at least one postoperative surveillance ultrasound. In the NIFTP-only cohort, no HT patients had completion thyroidectomy or received postoperative radioactive iodine. No recurrence or metastases were recorded with median follow-up of 35 months (6–76 months; n = 120).

Conclusions

Given this large cohort of NIFTP, including a large subset of isolated NIFTP-only, some with >6 years of follow-up and no tumor recurrences, consensus practical guidelines are needed for adequate postoperative management. Given the American Thyroid Association (ATA) provides guidelines for management of low-risk malignancies, guidance regarding that for borderline/biologically uncertain tumors, including NIFTP, is a reasonable next step.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAdenocarcinoma, FollicularHumansMaleFemaleMiddle AgedRetrospective StudiesIodine RadioisotopesNeoplasm Recurrence, Local

Stichwörter der Autor:innen

FNANIFTPmanagementmolecularsurveillance

Substanzen

Iodine Radioisotopes

Autor:innen und Institutionen

  • Departments of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Surgery, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Bayan A Alzumaili, Reagan Collins, William C Faquin, Peter M Sadow

Förderung

  • NCI NIH HHS

Zitieren

APA

Alzumaili, B. A., Krumeich, L. N., Collins, R., Kravchenko, T., Ababneh, E. I., Fisch, A. S., Faquin, W. C., Nosé, V., Martinez-Lage, M., Randolph, G. W., Gartland, R. M., Lubitz, C. C., & Sadow, P. M. (2023). A Comprehensive Study on the Diagnosis and Management of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid®, 33(5), 566-577. https://doi.org/10.1089/thy.2023.0035

Vancouver

Alzumaili BA, Krumeich LN, Collins R, Kravchenko T, Ababneh EI, Fisch AS, et al. A Comprehensive Study on the Diagnosis and Management of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid®. 2023;33(5):566-577. doi:10.1089/thy.2023.0035

BibTeX
@article{Alzumaili2023,
  author = {Alzumaili, Bayan A and Krumeich, Lauren N and Collins, Reagan and Kravchenko, Timothy and Ababneh, Emad I and Fisch, Adam S and Faquin, William C and Nosé, Vania and Martinez-Lage, Maria and Randolph, Gregory W and Gartland, Rajshri M and Lubitz, Carrie C and Sadow, Peter M},
  title = {A Comprehensive Study on the Diagnosis and Management of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features},
  journal = {Thyroid®},
  year = {2023},
  volume = {33},
  number = {5},
  pages = {566--577},
  doi = {10.1089/thy.2023.0035}
}
Kostenlos starten →